Pfizer’s Champix Faces Patent Hurdle In India As Dr Reddy’s Raise Questions
This article was originally published in The Pink Sheet Daily
Executive Summary
Dr. Reddy’s has been very selective in challenging Indian patents of multinational companies, so lawyers speculate that the undisclosed grounds for the challenge must be very strong.